Uncategorized

Colorado biotech Ambrosia lands $100M for oral GLP-1

Colorado biotech Ambrosia lands $100M for oral GLP-1

Published

7 days ago

on

A nascent biotech in the suburbs of Denver has convinced investors to commit $100 million to develop an oral small molecule in one of the most competitive fields in drug development.

Ambrosia Biosciences snagged the …​ ​Read More

Related Topics:

Leave a Reply

Your email address will not be published. Required fields are marked *

Trending

Exit mobile version